XTANDI Support Solutions Overview
XTANDI Support SolutionsSM, a component of Astellas Pharma Support SolutionsSM, offers services to help patients and healthcare providers with access and reimbursement. Whether you elect to go directly to one of the specialty pharmacies in our network or to XTANDI Support Solutions, reimbursement services focused on drug coverage and payer-specific requirements are available.
XTANDI Support Solutions provides information regarding patient healthcare coverage options and financial assistance programs to help patients with financial needs
Access 360 is an AstraZeneca owned and operated reimbursement hub. The services provided encompass benefit investigations and pharmacy research for providers as well as reimbursement support in addition to resources linking patients to our patient savings programs for our specialty products. The website for Access 360 is designed to service both providers and patients. The web address is www.MyAccess360.com. Patients and providers can also gain access to the same resources by contacting one of our internal service representatives at Access 360 (844) 275-2360.
Health insurance coverage and reimbursement issues can be confusing and challenging. Genentech Access Solutions is here to make the process as easy as possible.
Ipsen is proud to present IPSEN CARES, our IPSEN Coverage, Access, Reimbursement & Education Support program. The goal of IPSEN CARES is to simplify interactions between you, your insurance company, and your doctor’s office. With a wide range of valuable services, IPSEN CARES helps support your treatment process every step of the way.
IPSEN CARES helps you gain access to the medications that are important to your care and all related services, lessening the burden and stress of finding resources on your own.
With IPSEN CARES, you receive support from our Patient Access Specialists who can help:
- Provide copay assistance to eligible patients*
- Navigate your insurance coverage process and determine your out-of-pocket costs for treatment
- Provide free medication to eligible patients through the Patient Assistance Program (PAP)
- Avoid delays or interruptions to therapy
- Coordinate delivery through specialty pharmacies
Enrollment in IPSEN CARES is easy. Just call (866) 435-5677 to speak with an IPSEN CARES representative to begin enrollment. IPSEN CARES representatives are available from 8:00 AM to 8:00 PM ET (5:00 AM to 5:00 PM PT) Monday through Friday.
The operating companies of Johnson & Johnson have a long-standing commitment to helping patients access medicines. The operating companies of Johnson & Johnson donate free prescription medicines to the Johnson & Johnson Patient Assistance Foundation (JJPAF). JJPAF is an independent, private non-profit organization that assists patients without financial resources and prescription coverage to obtain free prescription products donated by the Johnson & Johnson operating companies. Products include Doxil, Procrit and Zytiga.
To learn more about the Foundation patient assistance programs or to apply for assistance, please visit our website jjpaf.org or call and speak to one of our Program Specialists at 800-652-6227.
PatientOne is the Lilly Oncology program that addresses financial, access, and claim issues for patients who are candidates for Lilly's Oncology products. Phone 1-866-472-8663
MAP can help answer questions about:
- Insurance coverage for patients
- Benefit investigations, prior authorizations, and appeals
- Co-pay assistance for eligible patients
- Referrals to the Merck Patient Assistance Program
Pfizer's patient assistance program is called Pfizer RxPathways.
Pfizer RxPathways offers a range of support services, including insurance counseling, co-pay help, and medicines provided free or at a savings. Eligibility requirements are the same as for the previous programs and vary by type of assistance. Patients who are currently receiving their medicines through Pfizer Helpful Answers and FirstResource will be automatically enrolled in Pfizer RxPathways and do not have to take any action to continue receiving their medicines.
YOU&i™ Support Program
Pharmacyclics LLC, An Abbvie Company, together with Janssen Biotech, Inc., created a unique set of patient support programs called YOU&i™ Support. This program is a personalized program that helps patients learn about access to IMBRUVICA® (ibrutinib), find affordability support options, and sign up for information and resources to support them along their treatment journey. The program provides patients with complimentary and personalized assistance while on IMBRUVICA® treatment by
* Contacting their insurance provider to help them understand benefits verification and appeals information
* Finding affordability options to help patients afford their treatment
* Providing educational disease state information
* Offering nurse call support that informs patients and responds to their questions
YOU&i™ Instant Savings Program
For eligible commercially insured patients, Pharmacyclics and Janssen Biotech offer the YOU&i™ Instant Savings Program to help with private insurance copay, deductible, and coinsurance costs for IMBRUVICA®. This program provides eligible patients who have commercial health insurance with the option to pay no more than $10 per month* for IMBRUVICA®.
*Month refers to a 30-day supply subject to a maximum benefit based on 12 monthly fills. Eligible patients may qualify for instant savings on their commercial insurance co-pay, deductible, and co-insurance medication costs for IMBRUVICA®. Not valid for federal and state healthcare program beneficiaries. Not valid for patients enrolled in Medicare or Medicaid.
YOU&i™ Start Program
For patients with insurance coverage decision delays, Pharmacyclics and Janssen Biotech offer the YOU&i Start Program. This program offers eligible new patients who have been
prescribed IMBRUVICA® for an FDA-approved indication, and who are experiencing an insurance coverage decision delay of more than 5 business days, a free 30-day supply of IMBRUVICA®. Under appropriate circumstances, an additional 30-day supply may be provided. The free product is offered to eligible patients without any purchase contingencies or other obligations.
Enrollment for the YOU&i™ Support Program can be completed either online at www.youandisupport.com, over the phone at 877-877-3536, or by faxing the enrollment form and related information to 800-752-5896.
IMBRUVICA® is dispensed through certain specialty pharmacies, including Avella Specialty Pharmacy, Biologics, Diplomat Specialty Pharmacy, and Onco360, and through the specialty distributors McKesson Specialty Health, Oncology Supply, ASD Healthcare, and McKesson Plasma & Biologics.
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for ADCETRISTM (brentuximab vedotin). Patient assistance is available to uninsured and underinsured patients that have been prescribed ADCETRIS. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include Benefit Investigations, assistance with underpaid/denied claims, ADCETRIS policy information and alternate funding research.
Please contact SeaGen Secure at 855.473.2436, Option 1 or www.SeaGenSecure.com to obtain an enrollment form or for additional information.
The Taiho Oncology Patient Support program strives to make the process of getting patients access to their LONSURF® (trifluridine and tipiracil) treatment as simple as possible. The program offers access and reimbursement support, specialty pharmacy prescription coordination, co-pay support for eligible commercially insured patients, patient assistance for eligible uninsured and under-insured patients, alternate funding support and, upon request, nursing support services. 1-844-TAIHO-4U (1-844-824-4648) or TaihoPatientSupport.com.
Takeda Oncology is committed to helping secure access to VELCADE® (bortezomib) for Injection for patients who have been prescribed VELCADE and have financial difficulties. Phone 1-866-835-2233